PAPA (Papa Medical) EBITDA Margin %: 7.99% (As of Mar. 2025)


What is Papa Medical EBITDA Margin %?

Papa Medical PAPA EBITDA Margin % is 7.99% as of Mar. 2025.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Papa Medical's EBITDA for the three months ended in Mar. 2025 was $1.43 Mil. Papa Medical's Revenue for the three months ended in Mar. 2025 was $17.87 Mil. Therefore, Papa Medical's EBITDA margin for the quarter that ended in Mar. 2025 was 7.99%.

Papa Medical  (NAS:PAPA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Papa Medical EBITDA Margin % Related Terms

Papa Medical EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Papa Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical EBITDA Margin % Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
EBITDA Margin %
11.29 9.16 6.16

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only 8.40 5.86 6.68 1.83 7.99

PAPA vs : EBITDA Margin % Comparison

For the Tobacco subindustry, Papa Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Papa Medical EBITDA Margin % vs Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, Papa Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Papa Medical's EBITDA Margin % falls into.


Papa Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Papa Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=2.322/37.719
=6.16 %

Papa Medical's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=1.427/17.869
=7.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 7.99% mean?
Papa Medical (PAPA) has a EBITDA Margin % of 7.99% as of Mar. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Papa Medical and its competitors.
Is Papa Medical's EBITDA Margin % too high?
Papa Medical's current EBITDA Margin % is 7.99%. The Tobacco Products industry median EBITDA Margin % is 11.19. Papa Medical's value of 7.99% is 28.6% below this industry median.
How does Papa Medical's EBITDA Margin % compare to ?
Papa Medical's EBITDA Margin % of 7.99% can be compared against companies in the Tobacco Products industry. The industry median EBITDA Margin % is 11.19. Papa Medical's value of 7.99% is 28.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Tobacco Products company?
The median EBITDA Margin % among Tobacco Products companies is 11.19, based on 48 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Papa Medical's current EBITDA Margin % of 7.99% is 28.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Papa Medical and its competitors. For the Tobacco Products industry, the median EBITDA Margin % is 11.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Papa Medical's current EBITDA Margin % is 7.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current EBITDA Margin % of 7.99%. The current EBITDA Margin % is 7.99% and 28.6% below the Tobacco Products industry median of 11.19. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Papa Medical (PAPA), the current EBITDA Margin % is 7.99% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.